Business · 16/04/2026
FDA Classifies Transcutaneous Electrical Nerve Stimulator for Congestion Relief
The FDA is classifying the transcutaneous electrical nerve stimulator for the relief of congestion into Class II, citing a reasonable assurance of safety and effectiveness, and aims to reduce regulatory burdens, enhancing patients' access to innovative devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →